AMPE

Ampio Pharmaceuticals Inc.
AMPE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings
 

About: Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee ("OAK") as part of its OA-201 development program ("OA-201 program" or "OA-201").

Employees: 6

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™